Both in Pharmaceuticals
Journey Medical vs Spruce Biosciences
Over the past year DERM returned −45.5% and SPRB returned −59.1%; their daily moves had a correlation of 0.17.
DERM −45.5% SPRB −59.1%Growth of $1, one year, split-adjusted
| Metric | DERM | SPRB |
|---|---|---|
| Price | $4.64 | $42.81 |
| Market cap | $131.0M | $123.0M |
| Today | −3.13% | −3.91% |
| 1 month | −30.6% | −5.7% |
| 6 months | −10.4% | −27.9% |
| Year to date | −39.8% | −50.9% |
| 1 year | −42.9% | −61.1% |
| Revenue growth (YoY) | +18.9% | — |
| Gross margin | 65.6% | — |
| Net margin | −1.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | — |
| Net cash | -$245.0K | $89.2M |
| Dividend yield | — | — |
| Volatility (60d) | 64.3% | 64.5% |
| Short % of float | 24.8% | 22.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).